QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Résumé Extracto Full Text PDF Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Articles Ahead of Print [Order Reprint] Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Citrome, L. L Articles by Jaffe, A. B Search for Related Content PubMed PubMed Citation Articles by Citrome, L. L Articles by Jaffe, A. B

THERAPEUTIC CONTROVERSIES

Relationship of Atypical Antipsychotics with Development of Diabetes Mellitus

Professor of Psychiatry, New York University School of Medicine, New York, NY; Director, Clinical Research and Evaluation Facility, Nathan S Kline Institute for Psychiatric Research, Orangeburg, NY

Ari B Jaffe, MD

Assistant Professor of Psychiatry, New York University

Reprints: Leslie L Citrome MD MPH, Nathan S Kline Institute for Psychiatric Research, 140 Old Orangeburg Rd., Orangeburg, NY 10962-2210, FAX 845/398-5483, citrome{at}nki.rfmh.org

OBJECTIVE: To review the pharmacoepidemiologic evidence for the link between exposure to atypical antipsychotics and the development of diabetes mellitus.

DATA SOURCES: A MEDLINE search (1990–March 2003) was conducted.

STUDY SELECTION AND DATA EXTRACTION: The search was limited to articles that described findings from analyses of large databases and used the words diabetes or hyperglycemia, and antipsychotic or clozapine or olanzapine or risperidone or quetiapine or ziprasidone or aripiprazole in the title or abstract. The odds ratio or relative risk, together with their corresponding confidence interval, was extracted.

DATA SYNTHESIS: Results are conflicting, and this variability may be due to the different populations studied, different study designs, and the possibility of publication bias related to funding by the pharmaceutical industry. Nevertheless, an increased risk for diabetes mellitus appears to be present for patients receiving atypical antipsychotics. However, differential risk among the atypical antipsychotics is difficult to ascertain.

CONCLUSIONS: Clinicians are urged to manage risk by regularly monitoring all patients receiving atypical antipsychotics for the emergence of diabetes mellitus. Future studies should carefully control for confounding variables such as age, diagnosis, change in weight, activity level, family history, and ethnicity.

Key Words: clozapine, diabetes mellitus, olanzapine, quetiapine, risperidone, ziprasidone

Published Online, November 5, 2003. www.theannals.com, DOI 10.1345/aph.1D142

This article has been cited by other articles:

				L. L Citrome, R. I. Holt, W. M Zachry, J. D Clewell, P. A Orth, J. L Karagianis, and V. P. Hoffmann Risk of Treatment-Emergent Diabetes Mellitus in Patients Receiving Antipsychotics Ann. Pharmacother., October 1, 2007; 41(10): 1593 - 1603. [Abstract] [Full Text] [PDF]

				M. V. Madsen, L. Peacock, T. Werge, and M. B. Andersen Effects of the cannabinoid CB1 receptor agonist CP55,940 and antagonist SR141716A on d-amphetamine-induced behaviours in Cebusmonkeys J Psychopharmacol, September 1, 2006; 20(5): 622 - 628. [Abstract] [PDF]

				L. Citrome, A. Jaffe, J. Levine, and D. Martello Incidence, Prevalence, and Surveillance for Diabetes in New York State Psychiatric Hospitals, 1997-2004 Psychiatr Serv, August 1, 2006; 57(8): 1132 - 1139. [Abstract] [Full Text] [PDF]

				J. S. Lamberti, D. Olson, J. F. Crilly, T. Olivares, G. C. Williams, X. Tu, W. Tang, K. Wiener, S. Dvorin, and M. B. Dietz Prevalence of the Metabolic Syndrome Among Patients Receiving Clozapine Am J Psychiatry, July 1, 2006; 163(7): 1273 - 1276. [Abstract] [Full Text] [PDF]

				R. I. G. Holt, C. Bushe, and L. Citrome Diabetes and schizophrenia 2005: are we any closer to understanding the link? J Psychopharmacol, November 1, 2005; 19(6_suppl): 56 - 65. [Abstract] [PDF]

				L. Citrome, A. Jaffe, J. Levine, B. Allingham, and J. Robinson Relationship Between Antipsychotic Medication Treatment and New Cases of Diabetes Among Psychiatric Inpatients Psychiatr Serv, September 1, 2004; 55(9): 1006 - 1013. [Abstract] [Full Text] [PDF]

				D. L. Leslie and R. A. Rosenheck Incidence of Newly Diagnosed Diabetes Attributable to Atypical Antipsychotic Medications Am J Psychiatry, September 1, 2004; 161(9): 1709 - 1711. [Abstract] [Full Text] [PDF]

				L. Citrome and J. Volavka Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes: Response to consensus statement Diabetes Care, August 1, 2004; 27(8): 2087 - 2088. [Full Text] [PDF]